Will Cannabis Seeds Be Restricted?
The redefinition of hemp under federal law, set to take place Nov. 12, spells the end of Farm Bill protections for many hemp-derived THC items across the country: low-dose beverages as well as THCA bud and delta-8 THC gummies, vapes and additional products sold at gas stops and smoke shops.
But the hemp prohibition also creates a major complication for the legitimate cannabis industry. Seeds from cannabis cultivars that produce flower with more than 0.3% THC are no longer legal to ship out of state.
Although seed buying will probably continue in legal states, the changes threaten to close some seed banks and https://nativesusa.com/ (nativesusa.com) genetics businesses, observers say, while causing supply-chain problems for cannabis cultivators and retailers.
“If this language goes forward, we will require pop-up stores to offer seeds in each state where it’s legal,” Campanella said. “Which is why we’re also offering clones and tissue cultivation, because that’s not included in the bill.”
When are cannabis genetics and clones prohibited to ship across state lines?
The new regulations classify seeds based on the THC capacity of the parent plant. Genetic material such as seeds and clones are made illegal if the final product crosses the threshold.
For the moment, seeds are still shipping under the 2018 Farm Bill’s status quo. But the clock is ticking for enterprises like Brothers Grimm and for cannabis growers who worry about supply chain interruptions if out-of-state access to genetics is prohibited.
Most of the cannabis industry remains largely unaware of the approaching shutdown of the interstate genetics market, said Ryan Power, co-founder of Sebastopol, California-based breeder Atlas Seed.
Without federal intervention in the way of a carve-out for seeds or a general moratorium, many seed providers will simply be shuttered come November, he added.
“We are operating legally now, but if that changes, it will disrupt the legitimate licensed industry in every state,” said Power, whose clientele includes seed suppliers as well as licensed business cultivators.
“Customers are going to forfeit choice, and it will be a significant shutdown for many people.”
What are cannabis seed suppliers doing to remain legal after the government hemp ban?
Sagui Silber has previously recalibrated Silberhaze Genetics, his Ohio genetics company, because of state Senate Bill 56, which tightened cannabis oversight in that state while also restricting hemp-derived THC products to licensed cannabis retailers.
Previously a seed bank, Silberhaze is currently focused on the marketing, preservation and IP safeguarding of premium plant genetics.
That’s because seed businesses hoping to stay compliant in this updated environment must have solid documentation, he said.
“You have to demonstrate where this stuff comes from, so it’s extremely important to have records, even to the point where you have cultivator names,” Silber said.
“Small businesses will have to operate with improved records and a stronger chain of custody,” he added. “We want that documentation too, because we don’t want to be dealing with questionable sources.”
To prevent seizures and other legal consequences, seed entrepreneurs must “get their affairs in order” before the new regulations take effect, Silber said.
“Review all your materials immediately, and categorize what you can,” Silber said. “Take inventory, document your lineage, preserve breeder records, and organize any cannabinoid or terpene data you already have. If regulations change, you’ll be in a much better position to understand what may be affected and make educated decisions.”
Does government marijuana rescheduling affect cannabis genetics?
Silber believes U.S. Drug Enforcement Administration licensing may be required for businesses engaged in research.
But for the time being, seed companies can’t register with the DEA like state-licensed medical cannabis operators can. Such a pathway is unavailable to seed banks, nurseries or genetics businesses, said Jim Ickes, an attorney and partner with Frantz Ward’s cannabis practice group in Cleveland.
“Genetics activity may be occurring inside larger state-licensed medical marijuana businesses, as some states allow dispensaries or registered medical operators to offer seeds, clones or home-cultivation materials,” he said.
“But that is distinct from the DEA establishing a freestanding seed bank registration category.”
Some genetics companies are already changing operational practices to comply with the updated law. According to Ickes, they must address questions including:
- Which of our lines produce plants over 0.3% total THC?
- Which seeds remain as hemp after Nov. 12, 2026, and which don’t?
- What does our inventory look like once we organize it against the viable-seed exclusion?
Ickes also understands confusion from clients who believed government rescheduling of medical marijuana would resolve their situation with banking institutions. However, the latest regulatory wording has moved those conversations beyond the fundamentals of classification, he said.
“Banks ask whether this specific revenue source is legal, whether it connects to state-licensed activity, or whether there’s interstate-commerce risk,” said Ickes.
“After November, a seed supplier selling drug-type genetics can’t answer the initial question with the hemp classification. It has to point to a legal state cannabis pathway instead. Seed banks dealing in genuine industrial-hemp seed maintain the simpler story.”
What’s the future of cannabis genetics?
Campanella is part of a emerging coalition of other breeders, growers and researchers that’s arguing seeds are better defined as farm inputs than regulated substances. To that end, seeds should be managed by the U.S. Department of Agriculture, leaving the DEA to focus its enforcement efforts elsewhere.
“How do you regulate something based on what it might become one day?” said Campanella. “Our choice is to have that wording removed, or get seeds regulated by the USDA as a hemp product.”
But in the interim, Campanella is restructuring Brothers Grimm to function outside the scope of changing federal oversight. The company plans to maintain its Colorado seed facility while positioning its Oklahoma tissue culture facility as a hedge against federal prohibition of cannabis seeds.
As she explained: “If things develop in a way where we can’t concentrate on interstate transport, we’ll have other resources to satisfy people’s needs without putting ourselves in trouble.”
